-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KITE-718 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KITE-718 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KITE-718 in Refractory Acute Myeloid Leukemia Drug Details: KITE-718...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Triplex in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Triplex in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Triplex in Mantle Cell Lymphoma Drug Details: Triplex is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lemzoparlimab in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lemzoparlimab in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lemzoparlimab in Primary Mediastinal B-Cell Lymphoma Drug Details: TJC-4...
-
Product Insights
NewQuarterly Sparkling Wine pricing trends in Brazil
Empower your strategies with our Quarterly Sparkling Wine pricing trends in Brazil report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewQuarterly Sparkling Wine pricing trends in the United Kingdom
Empower your strategies with our Quarterly Sparkling Wine pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewQuarterly Sparkling Wine pricing trends in Australia
Empower your strategies with our Quarterly Sparkling Wine pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Decitabine + Tetrahydrouridine) in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Decitabine + Tetrahydrouridine) in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Decitabine + Tetrahydrouridine) in B-Cell Non-Hodgkin Lymphoma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Riboflavin + Sodium Iodide) in Keratoconus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Riboflavin + Sodium Iodide) in Keratoconus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Riboflavin + Sodium Iodide) in Keratoconus Drug Details: A fixed-combination...
-
Product Insights
NewNet Present Value Model: Sumitomo Pharma Co Ltd’s EPI-589
Empower your strategies with our Net Present Value Model: Sumitomo Pharma Co Ltd's EPI-589 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EPI-004 in Cancer Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EPI-004 in Cancer Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EPI-004 in Cancer PainDrug Details:EPI-004 is under development for the treatment of chronic...